- Addressing Food Insecurity for People With Cancer
- Outcomes and Treatments of Patients With Non–Small Cell Lung Cancer Who Received Pembrolizumab
- Adult T-Cell Leukemia/Lymphoma and Targeted Maternal Screening
- Reassessing Treatment Outcomes Following Immune-Related Adverse Events
- JAMA Oncology
- Challenges in Interpreting MELATORCH Trial Outcomes
- Healthy Lifestyle Advice and Practice Among Cancer Survivors in the US
- Reassessing Treatment Outcomes Following Immune-Related Adverse Events—Reply
- Tiragolumab Plus Atezolizumab and Chemotherapy for Advanced Nonsquamous Non–Small Cell Lung Cancer
- Challenges in Interpreting MELATORCH Trial Outcomes—Reply
- Long-Term Outcomes in Patients With BRCA+ or PALB2+ Pancreatic Cancer Treated With Maintenance Rucaparib
- Rethinking Treatment Intent Beyond the Curative-Palliative Binary in Modern Oncology
- Multiple Spinal Intradural Tumors and a Pigmented Skin Lesion
- Embracing Highly Effective Obesity Therapies to Improve Cancer Treatment and Survivorship
- Clarification for Gleason Pattern
